Publication | Closed Access

Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter Study

UrologyRadiation TherapyGenitourinary CancerMedicineProspective Multicenter StudyPharmacotherapyCancer TreatmentPhase 2OncologyRadiation OncologyStereotactic Radiotherapy